← SearchNON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.$115,334N01FY2024DANIHIit Research Institute, Chicago ILInvestigatorsThomas HorncontactView original record on NIH RePORTER →